🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🙏🏼🙏🏼🙏🏼 Sincere thanks to Hagop Kantarjian,MD G Garcia-Manero Tapan Kadia for your leadership and mentorship towards the comprehensive and most amazing Leukemia Fellowship Program MD Anderson Cancer Center. Fadi Haddad, MD Emmanuel Almanza-Huante Alex Bataller Sai Desikan #ASH22 #leusm

Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia: The Randomized, Placebo-Controlled, Double-Blind, Phase III CLL12 Trial | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

Another my favorite #ASH2024 Tapan Kadia

Happy birthday ⁦Tapan Kadia⁩! How fun to celebrate ⁦⁦ASH⁩! 🧡

Beautiful presentation by Dr. Alexandre Bazinet in the AML oral session for upfront therapy: Clad/ldac/ven; CRc rate of 86% and 2-yr os of 62%

At 2 p.m. PT, a group of experts will be in #ASH24 booth 1949 to share more about about stem cell transplantation and leukemia fellowship programs at MD Anderson. (3/5) Qaiser Bashir G Garcia-Manero Tapan Kadia #EndCancer

#ASH24 Naveen Pemmaraju, MD Jessica Altman, MD Naval Daver, M.D. Tapan Kadia Sanam Loghavi, MD صنم لغوی 🔬🧬 Caitlin Rausch Hannah Goulart Dr Shira Diner 🙌 Dr C DiNardo Dr Alex Lovell 🙌

Just out! Fantastic paper by Naseema Gangat and colleagues: Mayo Clinic Genetic Risk models in Venetoclax-HMA treated Acute Myeloid Leukemia. AML #AyalewTefferi Tapan Kadia Mrinal Patnaik Aref Al-Kali nam12.safelinks.protection.outlook.com/?url=https%3A%…

#LeukemiaDreamTeam | ✅ An important meeting of the minds. Discussing brand new research ideas 💡 for 2025 together! Naveen Pemmaraju, MD Tapan Kadia Hannah Goulart Nitin Jain | #leusm #MPNSM #BPDCN #endcancer | MD Anderson Cancer Center 🙌

Proud of my wife Elise Nassif Haddad from #Sarcoma Medical Oncology at MD Anderson Cancer Center for receiving the Rising Star Award for Excellence in Clinical Care🏅 ✅ Multiple grants & awards in < 2 years as Faculty ‼️ Looking forward to seeing all your achievements in the sarcoma field 🙌

👉👉👉 Excited to welcome you to the inaugural Pan Pacific Leukemia Conference in Maui, Hawaii, July 15-18, 2025. Join collaboration of University of Nebraska and MD Anderson cc Julie Vose Vijaya R Bhatt, MBBS, MS Marina Konopleva Matt Lunning D.O. Hagop Kantarjian,MD Registration link

Adding venetoclax to intensive chemotherapy with cladribine, idarubicin, and cytarabine resulted in deep and durable remissions in young, fit patients with newly diagnosed #AML or #MDS, according to a study presented by Tapan Kadia of MD Anderson Cancer Center. 📰 buff.ly/42ozFT8

👉👉👉Saying a fond farewell andall of the best wishes today to our trusted friend & dear colleague Dr .Shilpa Paul as she leaves MD Anderson Cancer Center for her next journey!! Guillermo Montalban-Bravo Naveen Pemmaraju, MD Ashley Dinh | #endcancer #PharmD 🙏 🙏 🙏

Treated secondary #AML is an adverse subtype of AML that warrants an independent prognostic designation AmericanJournalofHematology onlinelibrary.wiley.com/doi/10.1002/aj…

New research from MD Anderson Cancer Center investigators presents outcomes in FLT3-mutated acute myeloid leukemia acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… Alex Bataller Tapan Kadia Naval Daver, M.D. Nicholas Short MD Musa Yilmaz, MD Gautam Borthakur Ghayas Issa Hagop Kantarjian,MD OncoAlert #LeuSM #AML

First report of the Ph 2 trial of the CLIA regimen in pts w/ R/R #AML: CR/CRi of 49% & median OS of 12 months in pts who received it as 1st salvage rx. Data provides tolerable & effective backbone upon which to build combination strategies ACS Journal Cancer doi.org/10.1002/cncr.3…

👉👉👉Our group’s new article led by Dr Hannah Goulart & Dr Tapan Kadia Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia AML acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… | ACS Journal Cancer MD Anderson Cancer Center #leusm #endcancer | Sanam Loghavi, MD صنم لغوی 🔬🧬

CLIA for patients with relapsed and/or refractory AML - Naveen Pemmaraju, MD Hannah Goulart Tapan Kadia Guillermo Chantada Sanam Loghavi, MD صنم لغوی 🔬🧬 oncodaily.com/url/278223 #CLIA #AML #Cancer #OncoDaily #Oncology #GlobalAwareness #FightAgainstCancer

👉👉👉Wonderful to get to spend some time with our friend & colleague @CRausch who is back in town this weekend ! Kayleigh Marx, PharmD, BCOP Tapan Kadia | #leusm

👉👉👉Azacitidine, Venetoclax and Magrolimab in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia: Phase 1b/2 Study and Correlative Analysis | Led by .Naval Daver, M.D. & Hussein Abbas aacrjournals.org/clincancerres/… | MD Anderson Cancer Center #leusm #endcancer Clinical Cancer Research Cancer Discovery